Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL827658 | 0.96 | — | — | |
| SCHEMBL9201379 | 0.72 | — | — | |
| SCHEMBL31376068 | 0.70 | — | — | |
| SCHEMBL1925361 | 0.67 | — | — | |
| SCHEMBL21728060 | 0.65 | — | — | |
| SCHEMBL329130 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL28718850 | 0.61 | — | — | |
| Water SCHEMBL31012143 | 0.59 | — | — | |
| SCHEMBL13156410 | 0.59 | — | — | |
| SCHEMBL29205011 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117285888-A | Composite conductive filler and anisotropic conductive adhesive film | 宁波连森电子材料有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-116676622-A | Preparation method and application of atomic-level dispersed single-layer iron phthalocyanine-based catalyst for electrochemical synthesis of ammonia | 浙江工业大学 | 2023-09-01 | — | — | CN | claimed |
| CN-115073373-A | Method for asymmetric synthesis of (R) -5' -methoxy labdanin | 广东嘉博制药有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-119731183-A | Solid forms of macrocyclic compounds as CFTR modulators and their preparation | 弗特克斯药品有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-115003656-B | [ (1, 4, 5-Trisubstituted 1H-pyrazol-3-yl) sulfanyl ] acetic acid derivatives and salts thereof and their use as active herbicidal ingredients | 拜耳公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119317748-A | Method for producing liquid-repellent fiber | 大金工业株式会社 | 2025-01-14 | — | — | CN | disclosed |
| CN-118974058-A | Preparation method and crystalline form of (6A, 12A) -17-amino-12-methyl-6, 15-bis (trifluoromethyl) -13, 19-dioxa-3,4,18-triazatricyclo [12.3.1.12,5] nonadeca-1 (18), 2,4,14,16-pentaen-6-ol | 弗特克斯药品有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118581533-A | Blind hole copper electroplating leveling agent, additive, electroplating solution and application thereof for PCB (printed circuit board) manufacturing process | 上海应用技术大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-114728915-B | [ (1, 5-Diphenyl-1H-1, 2, 4-triazol-3-yl) oxy ] acetic acid derivatives and salts thereof, crop protection compositions containing same, method for producing same, and use thereof as safeners | 拜耳公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-114071999-B | 1-Phenyl-5-azinylpyrazolyl-3-oxyalkyl acids and their use for controlling unwanted plant growth | 拜耳公司 | 2024-08-27 | — | — | CN | disclosed |
| CN-118317784-A | Pyrrolo-benzodiazepine derivative and conjugate thereof, and preparation method and application thereof | 江苏恒瑞医药股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-217410393-U | Blending liquid recycling equipment | 中天电子材料有限公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-105949178-B | Benzimidazole compound, preparation method, intermediate and application thereof | 西格莱(苏州)生物医药有限公司 | 2020-05-26 | — | — | CN | disclosed |
| US-RE40703-E1 | Cell differentiation inducer, benzamide compounds | SCHERING AKTIENGESELLSCHAFT (DE) | 2009-04-28 | — | — | US | disclosed |
| US-RE39754-E1 | Benzamide derivatives and pharmaceutical compositions containing same | SCHERING AG (DE) | 2007-07-31 | — | — | US | disclosed |
| EP-1020446-B1 | NAPHTHALIMIDOBENZAMIDE DERIVATIVES | TAIHO PHARMACEUTICAL CO LTD (JP) | 2006-03-15 | — | — | EP | disclosed |
| WO-2005066137-A1 | 2,5-DIARYL-1H-IMIDAZOLE-4-CARBOXAMIDES AS NEUROKININ-3 RECEPTOR MODULATORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM AND PERIPHERAL DISEASES | NEUROGEN CORPORATION (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050148601-A1 | Neurokinin-3 receptor modulators: diaryl imidazole derivatives | NEUROGEN CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-6300331-B1 | DRUGS AS ANTITUMOR AGENTS OR ANTICARCINOGENIC AGENTS | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2001-10-09 | — | — | US | disclosed |
| EP-1020446-A1 | NAPHTHALIMIDOBENZAMIDE DERIVATIVES | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2000-07-19 | — | — | EP | disclosed |